Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-006367
Filing Date
2022-02-15
Accepted
2022-02-15 09:00:44
Documents
1
Period of Report
2022-02-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4099
  Complete submission text file 0000899243-22-006367.txt   5462
Mailing Address C/O INSULET CORPORATION 600 TECHNOLOGY PARK DRIVE, SUITE 200 BILLERICA MA 01821
Business Address
Dorval Allison (Reporting) CIK: 0001625110 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40489 | Film No.: 22637188

Mailing Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 (978) 501-3026
Verve Therapeutics, Inc. (Issuer) CIK: 0001840574 (see all company filings)

IRS No.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations